Alzprotect
PrivateLast Round
Grant
Jun 1, 2022
Total Funding Raised
$26.29M
Company Overview
Alzprotect is a biopharmaceutical company that develops drug candidates for the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Progressive Supranuclear Palsy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alzprotect Comparables
Compare Alzprotect with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asceneuron | 85% | |
| Transposon Therapeutics | 79% | |
| Oligomerix, Inc. | 78% | |
Alzprotect Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2022 | ||||
| Corporate Funding | Jan 1, 2022 | ||||
| Series B | Jan 23, 2018 | ||||
| Series A Extension | Sep 21, 2016 | ||||
| Debt | Jun 11, 2014 | ||||
Series A | Jun 11, 2014 |
Key People
Founding team and executive leadership
Alzprotect Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xerys | Corporate Funding, Series B |
| Invest Securities | Series A Extension |
| Finorpa | Seed |
| Siparex Group | Corporate Funding, Seed, Series A, Series A Extension |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Finovam Gestion | Corporate Funding, Series A, Series A Extension |
| Bpifrance | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors increased 744% MoM, from 59 to 498.
- Aug 12, 2023
Grew 27% QoQ, from 11 to 14 employees.
Alzprotect Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alzprotect's valuation, stock price, and market status.